Theocharis Koufakis, Georgia Argyrakopoulou, Evangelos Fousteris, Sarantis Livadas, Alexander Kokkinos
{"title":"Words matter: Evidence that search terminology shapes the digital representation of obesity in Greece.","authors":"Theocharis Koufakis, Georgia Argyrakopoulou, Evangelos Fousteris, Sarantis Livadas, Alexander Kokkinos","doi":"10.1007/s42000-026-00841-9","DOIUrl":"https://doi.org/10.1007/s42000-026-00841-9","url":null,"abstract":"<p><strong>Background: </strong>Obesity stigma remains highly prevalent worldwide despite international recommendations promoting person-first language. Nonetheless, little is known regarding the digital representation of obesity in non-English-speaking settings. We aimed to compare the characteristics of Google search results generated using identity-first and person-first obesity terminology in Greece.</p><p><strong>Methods: </strong>Google searches were conducted in July 2026 using two Greek search terms corresponding to \"obese\" (identity-first terminology) and \"person with obesity\" (person-first terminology). The first 100 eligible organic results generated by each search term (total N = 200) were analyzed. Sources were categorized according to stakeholder type. An investigator-derived digital stigma score (range 0-5), incorporating linguistic, visual, and content-related characteristics, was developed.</p><p><strong>Results: </strong>Person-first search results were more likely to describe obesity as a chronic disease (46% vs. 10%) and originate from public health or advocacy organizations (24% vs. 2%) (all p < 0.001). Conversely, identity-first searches more frequently retrieved healthcare stakeholder sources (50% vs. 34%, p = 0.02) and stereotypical imagery (80% vs. 44%, p < 0.001). The digital stigma score was significantly higher among identity-first results (3.7 ± 0.9 vs. 1.8 ± 1.0; p < 0.001).</p><p><strong>Conclusions: </strong>Obesity-related terminology appears to shape the digital representation of obesity. Identity-first terminology was associated with a more stigmatizing and healthcare-oriented digital ecosystem, whereas person-first terminology preferentially retrieved patient-centered and public health-oriented content.</p>","PeriodicalId":520640,"journal":{"name":"Hormones (Athens, Greece)","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149389344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Independent and joint associations of social determinants of health and circadian syndrome with serum testosterone in adult males.","authors":"Renjie Huang, Miao Huang, Quanming Yang, Rui Zhang","doi":"10.1007/s42000-026-00838-4","DOIUrl":"https://doi.org/10.1007/s42000-026-00838-4","url":null,"abstract":"<p><strong>Purpose: </strong>To examine the association of a multidomain social determinants of health (SDoH) score with serum testosterone and to determine whether circadian syndrome (CircS) modifies this association in adult men.</p><p><strong>Methods: </strong>This cross-sectional study included 5,089 men from NHANES 2011-2016. Survey-weighted linear regression evaluated associations of an eight-component cumulative SDoH score and individual components with testosterone. Interaction terms assessed effect modification by CircS. Sensitivity analyses included a six-component score excluding marital and housing status.</p><p><strong>Results: </strong>In the fully adjusted model, each one-unit higher SDoH score was associated with 6.46 ng/dL higher testosterone (95% CI 3.81-9.10; P < 0.001), with a positive association across categories. Five component-specific associations were significant, not being married or living with a partner having the largest point estimate and housing tenure being another notable association. Excluding marital and housing status attenuated the association, but the six-component score remained significant (β = 4.97, 95% CI 1.72-8.23; P = 0.003). CircS modified the association (P for interaction = 0.010): it was positive in men without CircS (β = 7.94, 95% CI 5.12-10.76; P < 0.001) but not significant in men with CircS (β = -1.12, 95% CI - 7.59-5.35; P = 0.735). Multiple imputation and other sensitivity analyses supported the primary finding.</p><p><strong>Conclusion: </strong>Higher SDoH scores were associated with higher testosterone, with heterogeneous component-specific associations and attenuation in the presence of CircS. The cross-sectional design precludes causal inference.</p>","PeriodicalId":520640,"journal":{"name":"Hormones (Athens, Greece)","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149382663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Angeliki N Georgopoulou, Theodoros P Vassilakopoulos, Georgios K Markantes, Neoklis A Georgopoulos, Konstantinos Konstantopoulos, Marina P Siakantaris, Maria K Angelopoulou
{"title":"Chemotherapy-induced ovarian failure in females with Hodgkin lymphoma: current evidence and fertility preservation strategies.","authors":"Angeliki N Georgopoulou, Theodoros P Vassilakopoulos, Georgios K Markantes, Neoklis A Georgopoulos, Konstantinos Konstantopoulos, Marina P Siakantaris, Maria K Angelopoulou","doi":"10.1007/s42000-026-00836-6","DOIUrl":"https://doi.org/10.1007/s42000-026-00836-6","url":null,"abstract":"<p><p>Hodgkin lymphoma (HL) is a highly curable malignancy and increasing survival rates have shifted attention towards long-term treatment-related complications, particularly infertility among young women of reproductive age. Chemotherapy-induced ovarian damage is a multifactorial process that may lead to diminished ovarian reserve, premature ovarian failure, and impaired fertility. Several distinct mechanisms contribute to ovarian injury. Direct DNA damage to primordial follicles is the best-characterized pathway, resulting in apoptosis and irreversible depletion of the follicular pool. Chemotherapy also affects granulosa cells and ovarian stromal tissue, disrupting the microenvironment necessary for follicular growth and hormone production. In addition, vascular injury characterized by endothelial dysfunction, reduced ovarian perfusion, and cortical fibrosis may compromise follicular survival and contribute to long-term ovarian dysfunction. More recently, dysregulation of the PI3K/PTEN/Akt/mTOR signaling pathway has emerged as an important mechanism, promoting accelerated activation and premature exhaustion of primordial follicles, a phenomenon known as the \"burnout effect.\" These mechanisms frequently coexist and their relative contribution depends on treatment intensity, cumulative drug exposure, and patient-specific factors. Current fertility preservation strategies include oocyte, embryo, and ovarian tissue cryopreservation, while the uncertain efficacy of pharmacological ovarian suppression in HL highlights the need for further research into effective gonadoprotective approaches. This review summarizes current evidence regarding the biological mechanisms underlying chemotherapy-induced ovarian damage in women with HL and discusses their implications for fertility preservation and long-term reproductive health.</p>","PeriodicalId":520640,"journal":{"name":"Hormones (Athens, Greece)","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149291761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aristeidis Giannakopoulos, Amalia Sertedaki, Alexandra Efthymiadou, Eirini Kostopoulou, Dionisios Chrysis
{"title":"GNAI2 activating variants and MAGIS syndrome: long-term endocrine and growth outcome.","authors":"Aristeidis Giannakopoulos, Amalia Sertedaki, Alexandra Efthymiadou, Eirini Kostopoulou, Dionisios Chrysis","doi":"10.1007/s42000-026-00835-7","DOIUrl":"https://doi.org/10.1007/s42000-026-00835-7","url":null,"abstract":"<p><strong>Context: </strong>Germline activating variants in the GNAI2 gene have recently been associated with MAGIS syndrome, characterized by midline malformations of the brain, anterior pituitary gland dysfunction, growth retardation, immunodysregulation, and skeletal defects. However, the full phenotypic spectrum, particularly regarding endocrine dysfunction, remains incompletely defined.</p><p><strong>Case description: </strong>We report on a 9.5-year-old male presenting with MAGIS syndrome due to a de novo GNAI2 (NM_002070.4):c.544A>C, p.(Thr182Pro) variant. He initially presented at 17 months with short stature and hypopituitarism. Pituitary MRI confirmed anterior pituitary hypoplasia with thin stalk and normal posterior pituitary. Long-term follow-up revealed suboptimal response to recombinant growth hormone therapy with persistent low IGF-1, profound prolactin deficiency, and evolving gonadotropin deficiency. He also had delayed developmental milestones, recurrent infections, chronic diarrhea, subclinical hypothyroidism, and skeletal abnormalities. Immunological evaluation showed low T-cell counts, inadequate antibody responses and no overt autoimmune features apart from infantile atopic dermatitis.</p><p><strong>Conclusions: </strong>This report details the longitudinal clinical, endocrine, and growth data in a patient with MAGIS syndrome harboring a GNAI2 p.Thr182Pro variant. It highlights the suboptimal growth response to GH with fluctuating height velocity and the development of additional endocrine abnormalities such as prolactin, thyroid dysfunction and suspected gonadotropin deficiency. Detailed phenotypic characterization in such cases is crucial for understanding this complex genetic disorder.</p>","PeriodicalId":520640,"journal":{"name":"Hormones (Athens, Greece)","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149248119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zoe A Efstathiadou, Apostolos I Gogakos, Efstathios Divaris, Georgios Kostopoulos, Evangelia Makri
{"title":"Antidiabetic medications in the pipeline.","authors":"Zoe A Efstathiadou, Apostolos I Gogakos, Efstathios Divaris, Georgios Kostopoulos, Evangelia Makri","doi":"10.1007/s42000-026-00780-5","DOIUrl":"https://doi.org/10.1007/s42000-026-00780-5","url":null,"abstract":"<p><p>There is an extensive pipeline of therapies for diabetes mellitus. It has been known for the past three decades that obesity is a key pathophysiological player, involving inflammation, insulin resistance and metabolic dysfunction leading to type 2 diabetes and to significant cardiovascular, renal and hepatic complications, all central to the metabolic syndrome. On the basis of this knowledge and the disposition of drugs with multiple effects on different disease components, the diabetes therapeutic paradigm has shifted from merely glucocentric to multitargeted against these interconnected pathways.Much more recently, incretin-based multi-agonists have been developed that deliver unprecedented glycemic and weight benefits as well as weekly insulins and oral GLP-1 agonists that are able to reduce the burden of injectable therapies. An antibody-peptide conjugate that acts as a dual GLP-1/GIP receptor modulator has also shown promising results. Today, novel insulin sensitizers are modulating metabolic pathways towards higher energy expenditure with fewer side effects. Adjunctive agents for type 1 diabetes are improving glucose control while reducing hypoglycemia risk. Finally, drugs designed to restrain the inevitable muscle mass loss caused by antiobesity treatments are being tested. The diabetes pipeline is rich and there is hope that in the next few years, the therapeutic landscape will be further transformed with even more efficacious and individualized treatments.</p>","PeriodicalId":520640,"journal":{"name":"Hormones (Athens, Greece)","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149225691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Machine learning and penalized logistic regression-based models for the identification of potential characteristic genes in primary hyperparathyroidism.","authors":"Tianze Wang, Qila Sa, Boyuan Nan, Wei Zhang","doi":"10.1007/s42000-026-00832-w","DOIUrl":"https://doi.org/10.1007/s42000-026-00832-w","url":null,"abstract":"<p><strong>Purpose: </strong>Primary hyperparathyroidism (PHPT) is an endocrine disorder in which one or more parathyroid glands oversecrete parathyroid hormone, leading to hypercalcemia and potential complications such as kidney stones, bone fractures, and other systemic issues. Machine learning (ML) is extensively applied to diagnose medical diseases due to its high accuracy and ease of implementation.</p><p><strong>Methods: </strong>The microarray expression dataset (GSE83421) was selected from the Gene Expression Omnibus Database (GEO) for analysis. Differential expression analysis was performed with false discovery rate (FDR) correction. Weighted gene co-expression network analysis (WGCNA) identified correlated gene modules. Consensus feature selection using six algorithms (LASSO, SVM-RFE, random forest, Boruta, XGBoost, and decision tree) was applied to identify robust biomarkers and mitigate overfitting. A penalized logistic regression model was developed and evaluated using leave-one-out cross-validation (LOOCV).</p><p><strong>Results: </strong>Ten candidate genes were identified by intersecting 24 DEGs with the WGCNA red module. Consensus ML selected five hub genes (LOC51092, KIAA1479, PRO2214, TBX4, and ZNF361). T. The LOOCV-validated penalized logistic regression model effectively distinguished PHPT from normal controls.</p><p><strong>Conclusion: </strong>Our analysis identified a 5-gene signature (LOC51092, KIAA1479, PRO2214, TBX4, and ZNF361) with diagnostic potential for PHPT. The model was internally validated using LOOCV. However, without nested feature selection or external validation, the reported performance likely represents an optimistic estimate. Given the limited sample size, these findings represent preliminary hypotheses for PHPT diagnosis, requiring validation in independent cohorts.</p>","PeriodicalId":520640,"journal":{"name":"Hormones (Athens, Greece)","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149225674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kosmas Daskalakis, Konstantinos Ntalaperas, Nektaria Papadopoulou, Marina Tsoli, Anna Angelousi, Eva Kassi, Gregory Kaltsas
{"title":"How much is enough - surgical extent of initial parathyroidectomy and long-term outcomes in MEN1-related primary hyperparathyroidism.","authors":"Kosmas Daskalakis, Konstantinos Ntalaperas, Nektaria Papadopoulou, Marina Tsoli, Anna Angelousi, Eva Kassi, Gregory Kaltsas","doi":"10.1007/s42000-026-00828-6","DOIUrl":"https://doi.org/10.1007/s42000-026-00828-6","url":null,"abstract":"<p><strong>Context: </strong>Multiple endocrine neoplasia type 1 (MEN1)-associated primary hyperparathyroidism (pHPT) is typically multiglandular, which contributes to both persistent and recurrent disease following surgery. The optimal extent of initial parathyroidectomy in MEN1 remains debated.</p><p><strong>Objective: </strong>To evaluate long-term outcomes of subtotal parathyroidectomy (SPTX) and total parathyroidectomy with autotransplantation (TPTX-AT) versus less-than-subtotal parathyroidectomy (LSPTX) in MEN1-related pHPT, specifically regarding persistence, recurrence, permanent hypoparathyroidism, and need for reoperation.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted including 65 MEN1 patients who underwent initial parathyroidectomy and were followed at a single tertiary referral center. Patients were stratified according to surgical extent (LSPTX vs SPTX/TPTX-AT). Recurrence was analyzed only among patients who had documented initial postoperative normocalcemia and evaluable follow-up; Kaplan-Meier curves were constructed for recurrence-free survival. Multivariable Cox regression was applied to identify independent predictors of adverse outcomes.</p><p><strong>Results: </strong>The median follow-up was 133.1 months (range 2.4-442.2 months). Nineteen patients underwent LSPTX and 46 underwent SPTX/TPTX-AT. Among patients evaluable for recurrence, recurrent pHPT occurred in 13/19 (68.4%) after LSPTX versus 16/45 (35.6%) after SPTX/TPTX-AT (Fisher's exact test, p = .027). Permanent hypoparathyroidism at last follow-up occurred in 2/17 (11.8%) and 10/45 (22.2%), respectively (p = 0.484). Recurrence-free survival was significantly shorter after LSPTX (log-rank p<0.001). In a parsimonious Cox model adjusted for age at surgery, LSPTX remained associated with shorter recurrence-free survival compared with SPTX/TPTX-AT (HR 6.11 (95% CI 2.64-14.17).</p><p><strong>Conclusion: </strong>In MEN1-related pHPT, limited parathyroidectomy (LSPTX) is associated with significantly higher recurrence rates and shorter recurrence-free survival. Although the risk of permanent hypoparathyroidism appeared lower after LSPTX, this difference did not reach statistical significance. These findings support subtotal parathyroidectomy as the preferred initial surgical strategy in most MEN1 patients, while emphasizing lifelong biochemical surveillance.</p>","PeriodicalId":520640,"journal":{"name":"Hormones (Athens, Greece)","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149122743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Narjes Nasiri-Ansari, Aspasia Rizou, Christina-Maria Flessa, Manpal S Randeva, Eliana Spilioti, Maria-Eleni Chondrogianni, Lisa Dannenberg, Athanasios G Papavassiliou, Eva Kassi
{"title":"Effects of calcitriol (1,25(OH)₂D₃) on endothelial-derived factors implicated in atheromatous plaque vulnerability.","authors":"Narjes Nasiri-Ansari, Aspasia Rizou, Christina-Maria Flessa, Manpal S Randeva, Eliana Spilioti, Maria-Eleni Chondrogianni, Lisa Dannenberg, Athanasios G Papavassiliou, Eva Kassi","doi":"10.1007/s42000-026-00831-x","DOIUrl":"https://doi.org/10.1007/s42000-026-00831-x","url":null,"abstract":"<p><strong>Background: </strong>Atherosclerosis progresses from endothelial dysfunction to arterial plaque vulnerability, rupture, erosion, and calcification. Vitamin D deficiency is an independent cardiovascular risk factor associated with advanced atherosclerotic disease. This study investigated whether calcitriol (1,25(OH)₂D₃), the active hormonal form of vitamin D, modulates the expression of MMP-2, MMP-9, TIMP-1, TIMP-2, MCP-1, RANK, RANKL, and OPG in human aortic endothelial cells (HAECs).</p><p><strong>Methods: </strong>Cells were treated with calcitriol alone or in combination with TNF-α. Gene expression was assessed by qPCR, MCP-1 and OPG protein levels were measured by ELISA, and MMP activity by zymography.</p><p><strong>Results: </strong>Calcitriol did not significantly affect basal MMP-2, MMP-9, TIMP-1, or TIMP-2 expression but reduced MCP-1 mRNA at 10⁻⁸ M. In TNF-α-activated cells, pre-incubation of cells with calcitriol decreased MMP-9 and MCP-1 expression, restored TIMP-2 levels, elevated the pro-/active-MMP-2 ratio and increased OPG mRNA expression, although this transcriptional effect was not accompanied by a corresponding increase in OPG protein levels.</p><p><strong>Conclusion: </strong>The effects of calcitriol on human aortic endothelial cells suggest that calcitriol modulates inflammatory and extracellular matrix-remodeling markers in TNF-α-stimulated human aortic endothelial cells. Whether these changes contribute to plaque stability requires confirmation in more complex experimental models.</p>","PeriodicalId":520640,"journal":{"name":"Hormones (Athens, Greece)","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149122709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Weekday-weekend sleep patterning and testosterone outcomes in US men: a cross-sectional analysis of NHANES 2011-2014.","authors":"Renjie Huang, Miao Huang, Rui Zhang","doi":"10.1007/s42000-026-00833-9","DOIUrl":"https://doi.org/10.1007/s42000-026-00833-9","url":null,"abstract":"<p><strong>Purpose: </strong>Weekday-weekend differences in sleep duration are common, but their associations with testosterone and the specificity of corrected weekend catch-up sleep (CUS) as a sleep-pattern measure remain uncertain. We examined corrected CUS and related weekday-weekend sleep-pattern measures in relation to low and continuous total testosterone in US men.</p><p><strong>Methods: </strong>This cross-sectional analysis included 3,042 men aged ≥ 20 years from NHANES 2011-2014. Corrected CUS was defined as max (mean weekend sleep duration - mean weekday sleep duration, 0). Survey-weighted logistic and linear regression models examined biochemically low total testosterone and continuous total testosterone, with multiple imputation for missing covariates.</p><p><strong>Results: </strong>Low total testosterone was present in 883 participants (weighted prevalence, 28.0%). Compared with CUS = 0, only the highest positive corrected-CUS category (> 1.346 h) was associated with low total testosterone (OR 1.37, 95% CI 1.06-1.77) and lower continuous testosterone (- 28.90 ng/dL, 95% CI - 46.96 to - 10.84). The categorical low-testosterone association was not retained in complete-case, strict valid-night, or upper-tail-excluded analyses, whereas the corresponding continuous-testosterone contrast remained evident in the strict and upper-tail-excluded cohorts. Directional weekday-weekend and sleep-irregularity analyses did not support an association specific to weekend sleep extension.</p><p><strong>Conclusion: </strong>Corrected CUS showed modest cross-sectional associations with testosterone outcomes, but the broader pattern of results did not establish specificity to weekend sleep extension. Corrected CUS may instead reflect weekday-weekend sleep-pattern mismatch or broader sleep irregularity. These findings do not establish causality or support clinical use.</p>","PeriodicalId":520640,"journal":{"name":"Hormones (Athens, Greece)","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149066308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dimitrios Pappas, Ifigenia Kostoglou-Athanassiou, Georgios Troupis, George Mastorakos
{"title":"Lipodystrophies and female reproduction: pathophysiology, clinical spectrum, and management across the reproductive lifespan.","authors":"Dimitrios Pappas, Ifigenia Kostoglou-Athanassiou, Georgios Troupis, George Mastorakos","doi":"10.1007/s42000-026-00824-w","DOIUrl":"https://doi.org/10.1007/s42000-026-00824-w","url":null,"abstract":"<p><strong>Background: </strong>Lipodystrophies represent a heterogeneous group of rare disorders characterized by partial or generalized loss of adipose tissue, leading to severe metabolic derangements and endocrine dysfunction. In women, these disorders are frequently accompanied by reproductive abnormalities ranging from hypogonadotropic amenorrhea to hyperandrogenism and polycystic ovary syndrome-like phenotypes.</p><p><strong>Objective: </strong>To summarize current knowledge linking adipose-tissue dysfunction and female reproductive health, focusing on mechanistic pathways, clinical manifestations, fertility outcomes, contraception, pregnancy complications, and therapeutic perspectives including leptin replacement.</p><p><strong>Methods: </strong>A comprehensive review of PubMed and guideline literature (1996-2025) was performed, prioritizing official recommendations, registry data, and recent mechanistic and clinical studies.</p><p><strong>Results: </strong>Profound leptin deficiency in generalized lipodystrophy leads to hypothalamic suppression of gonadotropin-releasing hormone (GnRH) and amenorrhea, whereas hyperinsulinemia and androgen excess dominate partial forms, producing anovulation and infertility. Metreleptin therapy restores ovulatory cycles in leptin-deficient women and improves metabolic control, while pregnancy carries heightened risks of gestational diabetes, pre-eclampsia, and pancreatitis. Oral estrogens exacerbate hypertriglyceridemia; thus, progestin-only or non-hormonal contraception is preferred, and transdermal estrogen may be considered for hormone replacement.</p><p><strong>Conclusions: </strong>Female reproductive dysfunction in lipodystrophy results from complex interactions between leptin, insulin, and gonadal steroid pathways. A multidisciplinary approach is required to optimize metabolic and reproductive outcomes, while prospective data on fertility and pregnancy under metreleptin remain crucial for future practice.</p>","PeriodicalId":520640,"journal":{"name":"Hormones (Athens, Greece)","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149043122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}